Advertisements


Krystal Biotech"s KB103 receives orphan medicinal product designation in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2018

Krystal Biotech receives approval in Europe for gene therapy treatment

A gene therapy company has received a designation for one of its treatments from the European Medicines Agency. Krystal Biotech, developing and commercializing novel treatments for dermatological diseases, announced that KB103, a treatment for a sever.....»»

Category: topSource: bizjournalsApr 19th, 2018

AIM subsidiary receives orphan medicinal product designation for Ampligen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 24th, 2021

Krystal Biotech receives positive EMA opinion on orphan designation for KB105

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2019

Ocugen granted orphan medicinal product designation for OCU400 by EMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2021

Krystal Biotech Reports Third Quarter 2019 Financial and Operating Results

Alignment With FDA on GMP Commercial Manufacturing Process for KB103 (Bercolagene telserpavec, "B-VEC")KB105 Granted Fast Track Designation by the FDAPlatform Patent for Delivering any Effector to the Skin Granted by USPTO PITTSBURGH, .....»»

Category: earningsSource: benzingaNov 4th, 2019

Krystal Biotech Reports Second Quarter 2019 Financial and Operating Results

FDA grants RMAT designation for KB103 to treat dystrophic epidermolysis bullosa (DEB) Announced positive results from Phase 2 trial ("GEM-2") of KB103 Submitted an IND application .....»»

Category: earningsSource: benzingaAug 5th, 2019

Krystal Biotech shares up 27% after company"s skin drug receives expedited review designation from FDA

Shares of Krystal Biotech Inc. were up 27% in Monday intraday trade after the gene therapy company said it had receive.....»»

Category: topSource: marketwatchJun 24th, 2019

Proteostasis receives orphan drug designation for PTI-428 in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2019

Krystal Biotech receives PRIME eligibility for KB103 from EMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 29th, 2019

Moleculin Biotech receives orphan drug designation from FDA for WP1066

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2019

Instil Bio receives orphan drug designation for ITIL-168 in melanoma

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 27th, 2021

Curis receives FDA orphan drug designation for CA-4948

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2021

Praxis Precision Medicines receives orphan drug designation for PRAX-562

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2021

Curis receives FDA orphan drug designation for acute myeloid leukemia treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 5th, 2021

Passage Bio receives Orphan designation from European Commission for PBKR03

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 5th, 2021

Intellia Therapeutics treatment NTLA-2001 receives EU orphan drug designation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 30th, 2021

Moleculin Biotech receives FDA Fast Track Designation for Annamycin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 30th, 2021

Precigen receives FDA orphan drug designation for PRGN-2012

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 18th, 2021

Sigilon Therapeutics receives Orphan Drug Designation for SIG-007

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 5th, 2021

Exicure receives orphan drug designation for cavrotolimod from FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 3rd, 2021